Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Immunomodulation in presymptomatic type 1 diabetes: The Teplizumab breakthrough

Type 1 diabetes is a progressive autoimmune disease characterized by the destruction of insulin-producing pancreatic beta cells. Stage 2 T1D represents a critical asymptomatic window defined by the presence of two or more islet autoantibodies and dysglycemia, carrying an active, near-inevitable risk of progression to i...

A. Saha · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.